Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01729481. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
ClinicalTrials.gov study NCT00070278. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma
ClinicalTrials.gov study NCT06903273. IPD Sharing: YES. Countries: 1. Publications: 4.
Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery
ClinicalTrials.gov study NCT00335543. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00003762. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
ClinicalTrials.gov study NCT04233866. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01196559. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
ClinicalTrials.gov study NCT00064207. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
ClinicalTrials.gov study NCT00660140. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02146703. IPD Sharing: Not stated. Countries: 1. Publications: 12.
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01242605. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00193063. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
ClinicalTrials.gov study NCT02797977. IPD Sharing: NO. Countries: 2. Publications: 1.
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00004884. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
ClinicalTrials.gov study NCT01461915. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine
ClinicalTrials.gov study NCT02018874. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00023972. IPD Sharing: Not stated. Countries: 3. Publications: 1.
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
ClinicalTrials.gov study NCT01266720. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab
ClinicalTrials.gov study NCT02316327. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT01828736. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.